Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

• Main Authors: Mohammad Zamani (Author), Hossein Poustchi (Author), Zahra Mohammadi (Author), Sahar Dalvand (Author), Maryam Sharafkhah (Author), Seyed Abbas Motevalian (Author), Saeid Eslami (Author), Amir Emami (Author), Mohammad Hossein Somi (Author), Jamshid Yazdani-Charati (Author), Nader Saki (Author), Manoochehr Karami (Author), Farid Najafi (Author), Iraj Mohebbi (Author), Nasrollah Veisi (Author), Ahmad Hormati (Author), Farhad Pourfarzi (Author), Reza Ghadimi (Author), Alireza Ansari-Moghaddam (Author), Hamid Sharifi (Author), Gholamreza Roshandel (Author), Fariborz Mansour-Ghanaei (Author), Farahnaz Joukar (Author), Amaneh Shayanrad (Author), Sareh Eghtesad (Author), Ahmadreza Niavarani (Author), Alireza Delavari (Author), Soudeh Kaveh (Author), Akbar Feizesani (Author), Melineh Markarian (Author), Fatemeh Shafighian (Author), Alireza Sadjadi (Author), Maryam Darvishian (Author), Reza Malekzadeh (Author)
• Format: Book
• Published: BMC, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence of 17.1% among the general population in the first wave of the epidemic by April, 2020. The purpose of the current study was to assess the seroprevalence of COVID-19 infection among Iranian general popu...